Download Files:
Bempedoic acid
SKU
HY-12357-10 mg
Category Reference compound
Tags AMPK;ATP Citrate Lyase, Epigenetics;Metabolic Enzyme/Protease;PI3K/Akt/mTOR, Metabolic Disease
$61 – $495
Products Details
Product Description
– Bempedoic acid (ETC-1002) is an ATP-citrate lyase (ACL) inhibitor[1]. Bempedoic acid (ETC-1002) activates AMPK[2].
Web ID
– HY-12357
Storage Temperature
– -20°C, 3 years; 4°C, 2 years (Powder)
Shipping
– Room Temperature
Applications
– Metabolism-sugar/lipid metabolism
Molecular Formula
– C19H36O5
References
– [1]Pinkosky SL, et al. AMP-activated protein kinase and ATP-citrate lyase are two distinct molecular targets for ETC-1002, a novel small molecule regulator of lipid and carbohydrate metabolism. J Lipid Res. 2013 Jan;54(1):134-51.|[2]Filippov S, et al. ETC-1002 regulates immune response, leukocyte homing, and adipose tissue inflammation via LKB1-dependent activation of macrophage AMPK. J Lipid Res. 2013 Aug;54(8):2095-108.
CAS Number
– 738606-46-7
Molecular Weight
– 344.49
Compound Purity
– 98.0
SMILES
– O=C(O)C(C)(C)CCCCCC(O)CCCCCC(C)(C)C(O)=O
Clinical Information
– Launched
Research Area
– Metabolic Disease
Solubility
– DMSO : 100 mg/mL (ultrasonic)
Target
– AMPK;ATP Citrate Lyase
Isoform
– AMPK
Pathway
– Epigenetics;Metabolic Enzyme/Protease;PI3K/Akt/mTOR
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.